It simplifies the post-implant process for individuals, requiring minimal follow-up and no weekly recharging. "Valencia ...

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

which was marketed for a rare form of blindness and implanted in hundreds of patients Cortigent’s precision neurostimulation technology is also being developed for the recovery of arm and hand ...

The device does not require batteries, meaning further surgery to replace it are unnecessary. "Today, neurostimulators that treat OAB are large, bulky, and require complex and expensive surgery ...

is developing brain implant devices to help people recover critical body functions. Cortigent is a global leader in precision neurostimulation technology that provides meaningful visual perception ...